Magnetic resonance imaging-guided thrombolysis in minor stroke

International Journal of Stroke

Volumn 6, Issue 2, 2011, Pages 178-

  Desilles, Jean Philippe ^a   Cho, Tae Hee ^a,b   Hermier, Marc ^a   Mechtouff Cimarelli, Laura ^a   Derex, Laurent ^a,b   Nighoghossian, Norbert ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; LETTER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SAFETY; STROKE; TREATMENT OUTCOME;

EID: 79952308629     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00578.x     Document Type: Letter

References (5)

1. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56:1015-20.
2. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005; 36:2497-9.
3. Maas MB, Furie KL, Lev MH et al. National Institutes of Health Stroke Scale score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke 2009; 40:2988-93.
4. Thomalla G, Schwark C, Sobesky J et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006; 37:852-8.
5. Kruetzelmann A, Siemonsen S, Gerloff C et al. Thrombolysis targeting MRI defined tissue at risk in minor stroke. J Neurol Neurosurg Psychiatry 2009; 80:1156-8.